MedTrace Logo

Efficacy of Psychotherapy for Depressed Parkinson's Disease Patients

NCT02552836 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2024-03-19

No results posted yet for this study

Summary

The primary aim of this randomized controlled trial is to determine the acute antidepressant efficacy of interpersonal psychotherapy (IPT) in depressed patients with Parkinson's Disease.

Conditions

Interventions

BEHAVIORAL

Interpersonal Psychotherapy

A 12-week intervention that focuses on resolving interpersonal stressors that are linked to the onset, maintenance or exacerbation of depressive symptoms

BEHAVIORAL

Supportive Psychotherapy

A 12-week intervention that focuses on non-specific factors that contribute to therapy outcome

Sponsors & Collaborators

  • The Ottawa Hospital

    collaborator OTHER

  • Hopital Montfort

    lead OTHER

Principal Investigators

  • Diana Koszycki, PhD · Montfort Hospital and the University of Ottawa

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2023-03-31
Completion
2023-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02552836 on ClinicalTrials.gov